Douglas Wayne Arner
CIK: 0002149492
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NIKI
Niki BioSolutions, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Arner Douglas Wayne
Arner Douglas Wayne (SEC CIK 0002149492) files insider reports with the SEC as Director of Niki BioSolutions, Inc. (NIKI).
Signal8 holds 1 ownership filing by Arner Douglas Wayne, a Form 3, filed on Aug 13, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Arner Douglas Wayne's filings is in PRINCETON, NJ.
Other insiders filing for Niki BioSolutions, Inc. (NIKI)
- Philips Laura A, Director
- Sheinerman Kira, Director
- Wu Justin Che Yuen, Director
- Mireskandari Alidad, President, & COO